Records containing: Triple Negative Breast Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-04-15An Open Label, Phase II Trial of Afatinib With Paclitaxel for the Neoadjuvant Treatment of Triple-Negative Breast Cancer and Research of Biomarkers of Activity and Efficacy of Afatinib
-
CLINICAL_TRIALS study record update · 2016-03-17ClinicalTrials.gov study NCT00813956
-
CLINICAL_TRIALS study record update · 2016-02-22A Phase II Randomized Multicenter Open Label Prospective Study of Neoadjuvant Chemotherapy Docetaxel With or Without MEK Inhibitor SELUMETINIB in Patients With Early and Locally Advanced Triple Negative Breast Cancer
-
CLINICAL_TRIALS study record update · 2016-02-15A Phase II, Open Label, Controlled Study of Olaparib in Locally Advanced ER, PgR and HER2 Negative (Triple Negative) and in Locally Advanced Germline BRCA Mutation-positive Breast Cancer Patients: Biological Evaluation From a "Window of Opportunity" Trial
-
CLINICAL_TRIALS study record update · 2015-11-30ClinicalTrials.gov study NCT02616848
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-11-26ClinicalTrials.gov study NCT02615457
-
CLINICAL_TRIALS study record update · 2015-11-05An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer
-
CLINICAL_TRIALS study record update · 2015-11-03ClinicalTrials.gov study NCT02595138
-
CLINICAL_TRIALS study record update · 2015-10-20Clinical Study of Chimeric Mesothelin Antigen Receptor-modified T Cells in Relapsed and/or Chemotherapy Refractory Malignancies
-
CLINICAL_TRIALS study record update · 2015-02-16A Phase II Study of NK012 in Locally Advanced Non-Resectable and Metastatic Breast Cancer Patients With Triple Negative Phenotype
-
CLINICAL_TRIALS study record update · 2014-11-13A Multi-center, III Phase，Randomized Controlled Clinical Study of Capecitabine Metronomic Chemotherapy After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer
-
CLINICAL_TRIALS study record update · 2014-11-05Phase 2 Study of Two Consequent Chemotherapy Regimens as Induction Preoperative Therapy for Patients With Locally Advanced Triple Negative Breast Cancer
-
CLINICAL_TRIALS study record update · 2013-07-23Triple Negative Breast Cancer Biomarker Study
-
CLINICAL_TRIALS study record update · 2011-11-16Phase IIb Trial of Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Epirubicin as Neoadjuvant Treatment in Locally Advanced Triple-negative Breast Cancer